Novel Detection and Progression Markers for Diabetes Based on Continuous Glucose Monitoring Data Dynamics
The Journal of Clinical Endocrinology & Metabolism · 18.12.2024 · 110 (1) · 254-262
DOI: 10.1210/clinem/dgae379 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Journal of Clinical Endocrinology & Metabolism, online erschienen am 31.05.2024. Verfasst von Eslam Montaser und 2 weiteren Autor:innen. Beteiligte Einrichtung: Division of Endocrinology and Metabolism, Department of Medicine, Indiana University School of Medicine, Indianapolis, IN 46202, USA. Hauptthemen laut MEDLINE: Diabetes Mellitus, Type 1, Blood Glucose Self-Monitoring, Blood Glucose, Disease Progression. Die Arbeit wurde bisher 44-mal zitiert (Crossref) und nennt 42 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIH HHS, National Institute of Allergy and Infectious Diseases, University of Virginia.
Themen: Diabetes mellitus
Abstract (Originalsprache)
Context
Static measures of continuous glucose monitoring (CGM) data, such as time spent in specific glucose ranges (70-180 mg/dL or 70-140 mg/dL), do not fully capture the dynamic nature of blood glucose, particularly the subtle gradual deterioration of glycemic control over time in individuals with early-stage type 1 diabetes.
Objective
Develop a diabetes diagnostic tool based on 2 markers of CGM dynamics: CGM entropy rate (ER) and Poincaré plot (PP) ellipse area (S).
Methods
A total of 5754 daily CGM profiles from 843 individuals with type 1, type 2 diabetes, or healthy individuals with or without islet autoantibody status were used to compute 2 individual dynamic markers: ER (in bits per transition; BPT) of daily probability matrices describing CGM transitions between 8 glycemic states, and the area S (mg2/dL2) of individual CGM PP ellipses using standard PP descriptors. The Youden index was used to determine “optimal” cut-points for ER and S for health vs diabetes (case 1); type 1 vs type 2 (case 2); and low vs high type 1 immunological risk (case 3). The markers’ discriminative power was assessed through the area under the receiver operating characteristics curves (AUC).
Results
Optimal cutoff points were determined for ER and S for each of the 3 cases. ER and S discriminated case 1 with AUC = 0.98 (95% CI, 0.97-0.99) and AUC = 0.99 (95% CI, 0.99-1.00), respectively (cutoffs ERcase1 = 0.76 BPT, Scase1 = 1993.91 mg2/dL2), case 2 with AUC = 0.81 (95% CI, 0.77-0.84) and AUC = 0.76 (95% CI, 0.72-0.81), respectively (ERcase2 = 1.00 BPT, Scase2 = 5112.98 mg2/dL2), and case 3 with AUC = 0.72 (95% CI, 0.58-0.86), and AUC = 0.66 (95% CI, 0.47-0.86), respectively (ERcase3 = 0.52 BPT, Scase3 = 923.65 mg2/dL2).
Conclusion
CGM dynamics markers can be an alternative to fasting plasma glucose or glucose tolerance testing to identify individuals at higher immunological risk of progressing to type 1 diabetes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Endocrinology and Metabolism, Department of Medicine, Indiana University School of Medicine, Indianapolis, IN 46202, USA.
- Center for Diabetes Technology, School of Medicine, University of Virginia, Charlottesville, VA 22903, USA.
- Division of Endocrinology and Metabolism, Department of Medicine, School of Medicine, University of Virginia, Charlottesville, VA 22903, USA.
ORCID-Profile: Eslam Montaser, Leon S Farhy, Boris P Kovatchev
Förderung
- NIH HHS
- National Institute of Allergy and Infectious Diseases
- University of Virginia
- Commonwealth Research Commercialization Fund
- NIDDK NIH HHS
- Eunice Kennedy Shriver National Institute of Child Health and Human Development, and the JDRF
- Dexcom, Inc
- NIH
Zitieren
APA
Montaser, E., Farhy, L. S., & Kovatchev, B. P. (2024). Novel Detection and Progression Markers for Diabetes Based on Continuous Glucose Monitoring Data Dynamics. The Journal of Clinical Endocrinology & Metabolism, 110(1), 254-262. https://doi.org/10.1210/clinem/dgae379
Vancouver
Montaser E, Farhy LS, Kovatchev BP. Novel Detection and Progression Markers for Diabetes Based on Continuous Glucose Monitoring Data Dynamics. The Journal of Clinical Endocrinology & Metabolism. 2024;110(1):254-262. doi:10.1210/clinem/dgae379
BibTeX
@article{Montaser2024,
author = {Montaser, Eslam and Farhy, Leon S and Kovatchev, Boris P},
title = {Novel Detection and Progression Markers for Diabetes Based on Continuous Glucose Monitoring Data Dynamics},
journal = {The Journal of Clinical Endocrinology & Metabolism},
year = {2024},
volume = {110},
number = {1},
pages = {254--262},
doi = {10.1210/clinem/dgae379}
}
EUVIMED